News
Archive
Trellis Bioscience raises $9 million to advance clinical development of calpurbatug (TRL1068)
Paragraf growth designs accelerated with addition of industry heavyweights to Advisory Committee and Board of Directors
NASA awards PlanetiQ contract to expand access to Commercial Polarimetric GNSS Radio Occultation Satellite Data
Antevia Networks secures JOSCAR Accreditation as qualified supplier to aerospace, defence and security sectors
PlanetiQ advances atmospheric intelligence through high-performance GNSS-RO technology
Paragraf introduces PMF2000 GFET
Back To News
May 11, 2021
Vascular Therapies announces clinical results from its Phase 3 randomized multicenter clinical trial
Vascular Therapies, a privately held biotechnology company is developing Sirogen, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today the company announced clinical results from its Phase 3 clinical trial in which Sirogen showed encouraging AV fistula outcomes in elderly end-stage renal disease patients.